Nigerian Viread Study Called Off

A U.S. organization running a clinical trial in Nigeria to test whether the anti-HIV drug Viread is effective in preventing HIV infections in high-risk populations has called off the study because of the failure of local researchers to meet international scientific standards, London's Financial Times reports. Family Health International called off the study that would have involved hundreds of sex workers at high risk for HIV infection.

The Advocate (http://www.advocate.com/new_news.asp?ID=15443&sd=03/17/05)